Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 16.91
(1.74%)
CNY 16.91
(1.74%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 16.68 Million CNY | -48.06% |
| 2022 | 32.13 Million CNY | 32.4% |
| 2021 | 24.26 Million CNY | -19.24% |
| 2020 | 30.04 Million CNY | -65.91% |
| 2019 | 88.13 Million CNY | -15.26% |
| 2018 | 104 Million CNY | -5.02% |
| 2017 | 109.5 Million CNY | -9.5% |
| 2016 | 121 Million CNY | 77.94% |
| 2015 | 68 Million CNY | 63.5% |
| 2014 | 41.59 Million CNY | 0.0% |
| 2013 | - CNY | -100.0% |
| 2012 | 20 Million CNY | -33.33% |
| 2011 | 30 Million CNY | -25.0% |
| 2010 | 40 Million CNY | -20.0% |
| 2009 | 50 Million CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 7.78 Million CNY | 0.0% |
| 2024 Q2 | 17.18 Million CNY | 0.0% |
| 2024 Q1 | 16.39 Million CNY | 0.0% |
| 2023 FY | 16.68 Million CNY | -48.06% |
| 2023 Q2 | 26.72 Million CNY | 1.77% |
| 2023 Q1 | 26.26 Million CNY | -18.27% |
| 2023 Q3 | 25.98 Million CNY | -2.76% |
| 2023 Q4 | 16.68 Million CNY | -35.79% |
| 2022 Q4 | 32.13 Million CNY | 37.44% |
| 2022 Q2 | 24.36 Million CNY | 0.99% |
| 2022 Q1 | 24.12 Million CNY | -0.6% |
| 2022 FY | 32.13 Million CNY | 32.4% |
| 2022 Q3 | 23.37 Million CNY | -4.04% |
| 2021 Q2 | 53.06 Million CNY | 0.9% |
| 2021 Q1 | 52.58 Million CNY | 75.01% |
| 2021 FY | 24.26 Million CNY | -19.24% |
| 2021 Q4 | 24.26 Million CNY | -1.46% |
| 2021 Q3 | 24.62 Million CNY | -53.59% |
| 2020 Q3 | 42.06 Million CNY | 0.0% |
| 2020 Q2 | 42.06 Million CNY | -6.68% |
| 2020 FY | 30.04 Million CNY | -65.91% |
| 2020 Q1 | 45.07 Million CNY | -48.86% |
| 2020 Q4 | 30.04 Million CNY | -28.56% |
| 2019 FY | 88.13 Million CNY | -15.26% |
| 2019 Q3 | 134 Million CNY | -5.96% |
| 2019 Q1 | 162.5 Million CNY | 56.25% |
| 2019 Q2 | 142.5 Million CNY | -12.31% |
| 2019 Q4 | 88.13 Million CNY | -34.23% |
| 2018 Q3 | 122 Million CNY | 0.0% |
| 2018 Q2 | 122 Million CNY | -1.61% |
| 2018 FY | 104 Million CNY | -5.02% |
| 2018 Q1 | 124 Million CNY | 13.24% |
| 2018 Q4 | 104 Million CNY | -14.75% |
| 2017 Q2 | 113 Million CNY | -6.61% |
| 2017 Q3 | 118.8 Million CNY | 5.13% |
| 2017 Q4 | 109.5 Million CNY | -7.83% |
| 2017 Q1 | 121 Million CNY | 0.0% |
| 2017 FY | 109.5 Million CNY | -9.5% |
| 2016 Q1 | 118 Million CNY | 73.53% |
| 2016 Q4 | 121 Million CNY | -15.38% |
| 2016 FY | 121 Million CNY | 77.94% |
| 2016 Q3 | 143 Million CNY | -5.3% |
| 2016 Q2 | 151 Million CNY | 27.97% |
| 2015 Q2 | 41.59 Million CNY | 0.0% |
| 2015 FY | 68 Million CNY | 63.5% |
| 2015 Q4 | 68 Million CNY | 63.5% |
| 2015 Q1 | 41.59 Million CNY | 0.0% |
| 2015 Q3 | 41.59 Million CNY | 0.0% |
| 2014 Q4 | 41.59 Million CNY | 0.0% |
| 2014 FY | 41.59 Million CNY | 0.0% |
| 2014 Q3 | 41.59 Million CNY | 105.99% |
| 2014 Q2 | 20.19 Million CNY | 18.76% |
| 2014 Q1 | 17 Million CNY | 0.0% |
| 2013 Q3 | - CNY | -100.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | -100.0% |
| 2013 Q1 | 20 Million CNY | 0.0% |
| 2013 Q2 | 20 Million CNY | 0.0% |
| 2012 FY | 20 Million CNY | -33.33% |
| 2012 Q2 | 30 Million CNY | 0.0% |
| 2012 Q3 | 20 Million CNY | -33.33% |
| 2012 Q4 | 20 Million CNY | 0.0% |
| 2012 Q1 | 30 Million CNY | 0.0% |
| 2011 Q3 | 30 Million CNY | -25.0% |
| 2011 FY | 30 Million CNY | -25.0% |
| 2011 Q4 | 30 Million CNY | 0.0% |
| 2011 Q1 | 40 Million CNY | 0.0% |
| 2011 Q2 | 40 Million CNY | 0.0% |
| 2010 Q2 | 50 Million CNY | 0.0% |
| 2010 FY | 40 Million CNY | -20.0% |
| 2010 Q4 | 40 Million CNY | 0.0% |
| 2009 FY | 50 Million CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |